The first analysis in this group of related projects compared, for elderly female patients (>=65 years), locoregional (breast and axillary) surgery, the use of radiotherapy after breast-conserving surgery, and survival between six European countries (The Netherlands, Switzerland, Ireland, Belgium, Germany, Portugal) and the USA for the period 1995-2005 (Kiderlen et al. 2012 [9]). The aim of the study was to contribute to guidance on treatment for an age-group not well represented in clinical trials of breast cancer treatment. A further analysis is examining both locoregional and systemic treatment (including chemotherapy and hormonal therapy) in breast cancer patients diagnosed at >=65 years of age, comparing The Netherlands and Ireland. Analysis is also underway to compare treatment and survival between a range of European countries for all age-groups, as a pilot study for the EURECCA [10] (European Registration of Cancer Care) Breast project.
Links
[1] https://www.ncri.ie/research-status/ongoing
[2] https://www.ncri.ie/cancers/breast
[3] https://www.ncri.ie/research-theme/descriptive-epidemiology
[4] https://www.ncri.ie/research-theme/health-services-research
[5] https://www.ncri.ie/research-workstream/cancer-incidence-treatment-mortality-surveillance
[6] https://www.ncri.ie/research-workstream/cancer-survival
[7] https://www.ncri.ie/research-workstream/patterns-determinants-and-experiences-cancer-treatment
[8] https://www.ncri.ie/https
[9] http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303082/
[10] http://www.canceraudit.eu/
[11] https://www.ncri.ie/news/article/treatment-and-survival-older-breast-cancer-patients-international-comparison
[12] https://www.ncri.ie/research/scientific-papers/treatment-strategies-and-survival-older-breast-cancer-patients
[13] https://www.ncri.ie/research/scientific-papers/surgical-treatment-early-stage-breast-cancer-elderly-international
[14] https://www.ncri.ie/email/node/646/field_contact_email